Cash flow Eli Lilly and Company

Equities

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 17/04/2026 BST			5-day change	1st Jan Change
927.03 ^USD	+2.55%		-1.32%	-13.74%

04-17	Health Care Up Ahead of Earnings - Health Care Roundup	DJ
04-17	Kailera makes a splash on Nasdaq as anti-obesity drug frenzy continues

a0ca8d6a659687f40.kBVAKqHq9-lsDWnnS5xOOMlMxOKuA8LEsgKAwoOzGjQ.910jQMnao7k_XlGBc9t4QYwa8oj3e6T8h2P18vKDLG3bShdl0ceRiCJmIA

Published financial data: ELI LILLY AND COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	28.32B	28.54B	34.12B	45.04B	65.18B
Total Revenues	28.32B	28.54B	34.12B	45.04B	65.18B
Cost of Goods Sold, Total	6.97B	6.63B	7.08B	8.42B	11.05B
Gross Profit	21.35B	21.91B	27.04B	36.62B	54.13B
Selling General & Admin Expenses, Total	6.14B	6.07B	6.94B	8.13B	11.09B
R&D Expenses	7.03B	7.19B	9.31B	10.99B	13.34B
Other Operating Expenses, Total	13.17B	13.26B	16.25B	19.12B	24.43B
Operating Income	8.18B	8.65B	10.79B	17.5B	29.7B
Interest Expense, Total	-340M	-332M	-486M	-781M	-
Interest And Investment Income	25.4M	62.8M	174M	175M	-
Net Interest Expenses	-314M	-269M	-312M	-605M	-
Currency Exchange Gains (Loss)	-205M	-191M	-26.4M	-288M	-
Other Non Operating Income (Expenses)	-85.1M	177M	-6.3M	263M	-571M
EBT, Excl. Unusual Items	7.57B	8.37B	10.44B	16.87B	29.12B
Restructuring Charges	-13M	-23M	-45.5M	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	518M	-411M	-20.2M	-49.5M	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-484M
In Process R&D Expenses	-875M	-908M	-3.8B	-3.28B	-2.91B
Legal Settlements	-	-	-	-435M	-
Other Unusual Items	-1.05B	-222M	-22.2M	-426M	-
EBT, Incl. Unusual Items	6.16B	6.81B	6.55B	12.68B	25.73B
Income Tax Expense	574M	562M	1.31B	2.09B	5.09B
Earnings From Continuing Operations	5.58B	6.24B	5.24B	10.59B	20.64B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	5.58B	6.24B	5.24B	10.59B	20.64B
Net Income - (IS)	5.58B	6.24B	5.24B	10.59B	20.64B
Net Income to Common Incl Extra Items	5.58B	6.24B	5.24B	10.59B	20.64B
Net Income to Common Excl. Extra Items	5.58B	6.24B	5.24B	10.59B	20.64B
Per Share Items
Net EPS - Basic	6.15	6.93	5.82	11.76	23
Basic EPS - Continuing Operations	6.15	6.93	5.82	11.76	23
Basic Weighted Average Shares Outstanding	907M	902M	900M	901M	897M
Net EPS - Diluted	6.12	6.9	5.8	11.71	22.95
Diluted EPS - Continuing Operations	6.12	6.9	5.8	11.71	22.95
Diluted Weighted Average Shares Outstanding	912M	905M	903M	904M	899M
Normalized Basic EPS	5.22	5.8	7.25	11.71	20.29
Normalized Diluted EPS	5.19	5.78	7.23	11.66	20.24
Dividend Per Share	3.4	3.92	4.52	5.2	6
Payout Ratio	55.3	56.62	77.65	44.2	26.09
American Depositary Receipts Ratio (ADR)	0.03	0.03	0.03	0.03	0.03
Supplemental Items
EBITDA	9.73B	10.18B	12.31B	19.27B	31.69B
EBITA	8.81B	9.23B	11.29B	18.05B	30.18B
EBIT	8.18B	8.65B	10.79B	17.5B	29.7B
EBITDAR	9.88B	10.32B	12.49B	19.48B	-
Effective Tax Rate - (Ratio)	9.32	8.25	20.05	16.49	19.79
Current Domestic Taxes	910M	2.2B	3.04B	3.34B	4.64B
Current Foreign Taxes	466M	548M	613M	1.43B	2.16B
Total Current Taxes	1.38B	2.75B	3.66B	4.77B	6.8B
Deferred Domestic Taxes	-977M	-2.11B	-2.38B	-2.21B	-1.15B
Deferred Foreign Taxes	175M	-78.2M	34.2M	-473M	-558M
Total Deferred Taxes	-802M	-2.19B	-2.34B	-2.68B	-1.71B
Normalized Net Income	4.73B	5.23B	6.53B	10.54B	18.2B
Interest Capitalized	-	-	-	-	-
Non-Cash Pension Expense	-120M	-205M	-282M	-323M	-311M
Supplemental Operating Expense Items
Advertising Expense	1.2B	1B	1.12B	1.44B	-
Marketing Expenses	-	-	-	-	2.9B
Selling and Marketing Expenses	1.2B	1B	1.12B	1.44B	2.9B
Research And Development Expense From Footnotes	7.9B	8.1B	13.11B	14.27B	16.25B
Net Rental Expense, Total	159M	149M	171M	210M	-
Imputed Operating Lease Interest Expense	25.12M	23.17M	31.07M	42.65M	-
Imputed Operating Lease Depreciation	134M	126M	140M	167M	-
Stock-Based Comp., Other (Total)	343M	371M	628M	646M	626M
Total Stock-Based Compensation	343M	371M	628M	646M	626M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.82B	2.07B	2.82B	3.27B	7.27B
Short Term Investments	90.1M	145M	109M	155M	-
Trading Asset Securities, Total	4.8M	230M	114M	10.3M	-
Total Cash And Short Term Investments	3.91B	2.44B	3.04B	3.43B	7.27B
Accounts Receivable, Total	6.67B	6.9B	9.09B	11.01B	17.76B
Other Receivables	1.44B	1.41B	2B	1.92B	2.36B
Total Receivables	8.11B	8.3B	11.09B	12.93B	20.12B
Inventory	3.89B	4.31B	5.77B	7.59B	13.74B
Prepaid Expenses	2.53B	2.95B	5.54B	8.34B	1.42B
Other Current Assets, Total	9.9M	26.6M	279M	448M	13.09B
Total Current Assets	18.45B	18.03B	25.73B	32.74B	55.63B
Gross Property Plant And Equipment	18.96B	20.38B	24.01B	29.94B	38.5B
Accumulated Depreciation	-9.98B	-10.23B	-11.1B	-11.79B	-12.56B
Net Property Plant And Equipment	8.99B	10.14B	12.91B	18.15B	25.94B
Long-term Investments	3.4B	3.2B	3.41B	3.27B	2.8B
Goodwill	3.89B	4.07B	4.94B	5.77B	5.9B
Other Intangibles, Total	7.69B	7.21B	6.91B	6.17B	6.52B
Deferred Tax Assets Long-Term	2.49B	2.79B	5.48B	8B	9.96B
Other Long-Term Assets, Total	3.89B	4.04B	4.64B	4.62B	5.73B
Total Assets	48.81B	49.49B	64.01B	78.71B	112B
Liabilities
Accounts Payable, Total	1.67B	1.93B	2.6B	3.23B	5.38B
Accrued Expenses, Total	7.88B	9.92B	13.42B	13.71B	19.76B
Short-term Borrowings	-	-	6.19B	4.34B	-
Current Portion of Long-Term Debt	1.54B	1.54B	746M	782M	1.64B
Current Portion of Leases	148M	154M	197M	176M	222M
Current Income Taxes Payable	127M	475M	-	-	-
Other Current Liabilities	3.69B	3.12B	4.14B	6.14B	8.24B
Total Current Liabilities	15.05B	17.14B	27.29B	28.38B	35.23B
Long-Term Debt	15.39B	14.87B	18.42B	28.64B	40.87B
Long-Term Leases	537M	574M	910M	971M	1.14B
Pension & Other Post Retirement Benefits	1.95B	1.31B	1.44B	1.3B	-
Deferred Tax Liability Non Current	1.73B	87.3M	-	-	-
Other Non Current Liabilities	4.99B	4.74B	5.08B	5.15B	8.7B
Total Liabilities	39.65B	38.71B	53.14B	64.44B	85.94B
Common Stock, Total	596M	594M	594M	592M	590M
Additional Paid In Capital	6.83B	6.92B	7.25B	7.44B	7.35B
Retained Earnings	8.96B	10.04B	10.31B	13.54B	24.47B
Treasury Stock	-52.7M	-50.5M	-44.2M	-49.5M	-
Comprehensive Income and Other	-7.36B	-6.86B	-7.34B	-7.34B	-5.87B
Total Common Equity	8.98B	10.65B	10.77B	14.19B	26.54B
Minority Interest	176M	126M	91.8M	79.5M	-
Total Equity	9.15B	10.78B	10.86B	14.27B	26.54B
Total Liabilities And Equity	48.81B	49.49B	64.01B	78.71B	112B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	902M	900M	900M	898M	893M
ECS Total Common Shares Outstanding	904M	900M	899M	898M	895M
Book Value / Share	9.94	11.83	11.98	15.81	29.65
Tangible Book Value	-2.6B	-630M	-1.07B	2.26B	14.12B
Tangible Book Value Per Share	-2.88	-0.7	-1.19	2.51	15.78
Total Debt	17.61B	17.14B	26.47B	34.91B	43.86B
Net Debt	12.42B	14.01B	22.71B	30.99B	36.37B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.15B	26.2M	549M	-243M	-558M
Debt Equivalent Oper. Leases	1.28B	1.19B	1.37B	1.68B	-
Minority Interest, Total (Incl. Fin. Div)	176M	126M	91.8M	79.5M	-
Equity Method Investments, Total	772M	781M	962M	1.14B	1.29B
Account Code - Inventory Valuation	4	4	4	4	-
LIFO Reserve, Total	34.2M	8.9M	102M	62.9M	43M
Inventories - Raw Materials, Total	717M	802M	1.63B	2.33B	3.59B
Inventories - Work In Process, Total	2.37B	2.6B	3.25B	3.98B	8.18B
Inventories - Finished Goods, Total	762M	901M	792M	1.22B	1.93B
Land - (BS)	259M	257M	320M	382M	647M
Buildings, Total	7.59B	7.92B	8.28B	8.81B	10.09B
Machinery, Total	8.94B	9.41B	10.33B	11.46B	13.49B
Full Time Employees	35K	39K	43K	47K	50K
Accumulated Allowance for Doubtful Accounts (Supple)	22.5M	16M	14.8M	14.9M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	5.58B	6.24B	5.24B	10.59B	20.64B
Depreciation & Amortization - CF	919M	943M	1.02B	1.21B	1.51B
Amortization of Goodwill and Intangible Assets - (CF)	629M	580M	506M	553M	488M
Depreciation & Amortization, Total	1.55B	1.52B	1.53B	1.77B	2B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-1.88B	-224M	-180M
(Gain) Loss on Sale of Investments - (CF)	-178M	420M	23.5M	49.8M	-
Asset Writedown & Restructuring Costs	875M	421M	3.8B	3.28B	2.91B
Stock-Based Compensation (CF)	343M	371M	628M	646M	626M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	114M	-1.88B	-2.05B	-1.91B	-1.09B
Change In Accounts Receivable	-1.28B	-300M	-2.45B	-2.16B	-7B
Change In Inventories	-236M	-600M	-1.42B	-2.51B	-4.67B
Change In Accounts Payable	-664M	1.33B	4.27B	2.61B	10.19B
Change In Income Taxes	-360M	347M	-	-	-
Change in Other Net Operating Assets	1.52B	-794M	-3.45B	-3.33B	-6.61B
Cash from Operations	7.26B	7.08B	4.24B	8.82B	16.81B
Capital Expenditure	-1.31B	-1.85B	-3.45B	-5.06B	-7.84B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-747M	-327M	-1.04B	-948M	-661M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-563M	-630M	-2.34B	-2.74B	-2.79B
Investment in Marketable and Equity Securities, Total	-166M	-244M	-129M	-253M	319M
Other Investing Activities, Total	24.3M	-206M	-192M	-298M	1M
Cash from Investing	-2.76B	-3.26B	-7.15B	-9.3B	-10.97B
Short Term Debt Issued, Total	-	1.5B	4.69B	-	-
Long-Term Debt Issued, Total	2.41B	-	3.96B	11.42B	13.17B
Total Debt Issued	2.41B	1.5B	8.65B	11.42B	13.17B
Short Term Debt Repaid, Total	-4M	-	-	-1.85B	-4.34B
Long-Term Debt Repaid, Total	-1.91B	-1.56B	-	-664M	-778M
Total Debt Repaid	-1.91B	-1.56B	-	-2.52B	-5.12B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.25B	-1.5B	-750M	-2.5B	-4.11B
Common Dividends Paid	-3.09B	-3.54B	-4.07B	-4.68B	-5.38B
Common & Preferred Stock Dividends Paid	-3.09B	-3.54B	-4.07B	-4.68B	-5.38B
Other Financing Activities, Total	-296M	-309M	-335M	-491M	-772M
Cash from Financing	-4.13B	-5.41B	3.5B	1.23B	-2.21B
Foreign Exchange Rate Adjustments	-206M	-168M	169M	-297M	372M
Net Change in Cash	161M	-1.75B	752M	450M	4B
Supplemental Items
Cash Interest Paid	338M	324M	404M	578M	633M
Cash Income Tax Paid (Refund)	1.6B	2.67B	5.56B	6.56B	10.81B
Levered Free Cash Flow	5.14B	5.49B	237M	1.32B	1.95B
Unlevered Free Cash Flow	5.35B	5.7B	541M	1.81B	1.95B
Change In Net Working Capital	-226M	-878M	2.57B	3.74B	8.6B
Net Debt Issued / Repaid	501M	-62M	8.65B	8.9B	8.05B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.71	11	11.88	15.33	19.42
Return on Total Capital	20.66	20.03	20.91	25.29	31.07
Return On Equity %	74.52	62.67	48.43	84.26	101.16
Return on Common Equity	76.35	63.63	48.93	84.84	101.16
Margin Analysis
Gross Profit Margin %	75.38	76.77	79.25	81.31	83.04
SG&A Margin	21.69	21.26	20.34	18.05	17.02
EBITDA Margin %	34.34	35.65	36.09	42.78	48.62
EBITA Margin %	31.1	32.35	33.09	40.08	46.31
EBIT Margin %	28.88	30.32	31.61	38.86	45.56
Income From Continuing Operations Margin %	19.71	21.88	15.36	23.51	31.67
Net Income Margin %	19.71	21.88	15.36	23.51	31.67
Net Avail. For Common Margin %	19.71	21.88	15.36	23.51	31.67
Normalized Net Income Margin	16.71	18.33	19.13	23.41	27.93
Levered Free Cash Flow Margin	18.16	19.23	0.69	2.93	2.99
Unlevered Free Cash Flow Margin	18.91	19.96	1.58	4.01	2.99
Asset Turnover
Asset Turnover	0.59	0.58	0.6	0.63	0.68
Fixed Assets Turnover	3.21	2.98	2.96	2.81	2.96
Receivables Turnover (Average Receivables)	4.51	4.21	4.27	4.48	4.53
Inventory Turnover (Average Inventory)	1.77	1.62	1.4	1.26	1.04
Short Term Liquidity
Current Ratio	1.23	1.05	0.94	1.15	1.58
Quick Ratio	0.8	0.63	0.52	0.58	0.78
Operating Cash Flow to Current Liabilities	0.48	0.41	0.16	0.31	0.48
Days Sales Outstanding (Average Receivables)	80.87	86.76	85.5	81.65	80.54
Days Outstanding Inventory (Average Inventory)	205.88	225.6	259.81	290.47	352.27
Average Days Payable Outstanding	86.95	93.18	96.73	104.2	91.3
Cash Conversion Cycle (Average Days)	199.79	219.19	248.58	267.92	341.52
Long Term Solvency
Total Debt/Equity	192.38	159.06	243.63	244.62	165.31
Total Debt / Total Capital	65.8	61.4	70.9	70.98	62.31
LT Debt/Equity	173.94	143.34	177.98	207.52	158.31
Long-Term Debt / Total Capital	59.49	55.33	51.79	60.22	59.67
Total Liabilities / Total Assets	81.24	78.23	83.03	81.87	76.41
EBIT / Interest Expense	24.07	26.1	22.2	22.42	-
EBITDA / Interest Expense	29.09	31.14	25.7	24.95	-
(EBITDA - Capex) / Interest Expense	25.23	25.54	18.6	18.47	-
Total Debt / EBITDA	1.78	1.66	2.12	1.79	1.37
Net Debt / EBITDA	1.26	1.36	1.82	1.59	1.14
Total Debt / (EBITDA - Capex)	2.05	2.02	2.93	2.42	1.82
Net Debt / (EBITDA - Capex)	1.45	1.65	2.51	2.15	1.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	15.4	0.79	19.56	32	44.7
Gross Profit, 1 Yr. Growth %	12.01	2.65	23.41	35.44	47.79
EBITDA, 1 Yr. Growth %	15.43	3.62	21.02	56.47	68.52
EBITA, 1 Yr. Growth %	16.96	3.72	22.31	59.88	71.57
EBIT, 1 Yr. Growth %	15.15	4.6	24.66	62.24	74.27
Earnings From Cont. Operations, 1 Yr. Growth %	-9.88	11.88	-16.08	102.08	94.9
Net Income, 1 Yr. Growth %	-9.88	11.88	-16.08	102.08	94.9
Normalized Net Income, 1 Yr. Growth %	15.11	4.5	24.76	61.56	73.15
Diluted EPS Before Extra, 1 Yr. Growth %	-9.87	12.74	-15.94	101.9	95.99
Accounts Receivable, 1 Yr. Growth %	13.57	3.34	31.82	21.07	61.37
Inventory, 1 Yr. Growth %	-2.37	10.9	33.95	31.46	81.1
Net Property, Plant and Equip., 1 Yr. Growth %	3.49	12.9	27.3	30.24	42.88
Total Assets, 1 Yr. Growth %	4.66	1.4	29.33	22.98	42.89
Tangible Book Value, 1 Yr. Growth %	-53.28	-75.82	70.59	-309.93	504.28
Common Equity, 1 Yr. Growth %	59.16	18.61	1.15	31.75	85.92
Cash From Operations, 1 Yr. Growth %	11.71	-2.43	-44.1	107.96	90.67
Capital Expenditures, 1 Yr. Growth %	-5.63	41.57	85.92	46.7	55.02
Levered Free Cash Flow, 1 Yr. Growth %	49.8	2.6	-95.51	375.58	44
Unlevered Free Cash Flow, 1 Yr. Growth %	46.4	2.4	-90.14	211.04	44
Dividend Per Share, 1 Yr. Growth %	14.86	15.29	15.31	15.04	15.38
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.64	7.85	9.77	25.62	38.2
Gross Profit, 2 Yr. CAGR %	10.13	7.23	12.56	29.28	41.48
EBITDA, 2 Yr. CAGR %	15.96	9.19	11.98	37.61	63.53
EBITA, 2 Yr. CAGR %	18.94	9.94	12.63	39.84	66.94
EBIT, 2 Yr. CAGR %	16.75	9.55	14.19	42.22	69.59
Earnings From Cont. Operations, 2 Yr. CAGR %	9.7	0.41	-3.11	30.22	98.47
Net Income, 2 Yr. CAGR %	-18.08	0.41	-3.11	30.22	98.47
Normalized Net Income, 2 Yr. CAGR %	16.06	11.87	14.18	41.97	67.17
Diluted EPS Before Extra, 2 Yr. CAGR %	11.08	0.81	-2.65	30.27	98.92
Accounts Receivable, 2 Yr. CAGR %	21.14	8.34	16.72	26.33	39.77
Inventory, 2 Yr. CAGR %	10.36	4.06	21.88	32.7	54.3
Net Property, Plant and Equip., 2 Yr. CAGR %	6.83	8.09	19.88	33.77	36.41
Total Assets, 2 Yr. CAGR %	11.46	3.02	14.52	26.12	32.56
Tangible Book Value, 2 Yr. CAGR %	-41.8	-66.39	-35.78	89.24	262.47
Common Equity, 2 Yr. CAGR %	85.59	37.39	9.53	15.44	56.95
Cash From Operations, 2 Yr. CAGR %	22.52	4.4	-24.13	7.82	99.13
Capital Expenditures, 2 Yr. CAGR %	12.55	15.59	62.24	65.15	50.8
Levered Free Cash Flow, 2 Yr. CAGR %	1.5	25.21	-79.17	-49.98	158.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	1.07	23.65	-69.13	-42.58	158.34
Dividend Per Share, 2 Yr. CAGR %	14.8	15.08	15.3	15.18	15.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.63	8.54	11.62	16.73	31.69
Gross Profit, 3 Yr. CAGR %	8.28	7.58	12.37	19.72	35.18
EBITDA, 3 Yr. CAGR %	8.4	12.06	13	25.19	46.04
EBITA, 3 Yr. CAGR %	11.3	14.04	13.92	26.58	48.42
EBIT, 3 Yr. CAGR %	10.71	12.99	14.37	28.37	50.84
Earnings From Cont. Operations, 3 Yr. CAGR %	21	10.42	-5.42	23.8	48.96
Net Income, 3 Yr. CAGR %	19.98	-9.11	-5.42	23.8	48.96
Normalized Net Income, 3 Yr. CAGR %	8.49	14.18	16.01	28.19	51.53
Diluted EPS Before Extra, 3 Yr. CAGR %	26.13	11.63	-5.12	24.15	49.27
Accounts Receivable, 3 Yr. CAGR %	13.25	14.89	15.66	18.15	37.07
Inventory, 3 Yr. CAGR %	7.85	10.54	13.19	25	47.19
Net Property, Plant and Equip., 3 Yr. CAGR %	3.96	8.82	14.15	26.42	36.74
Total Assets, 3 Yr. CAGR %	3.59	8	11.13	17.27	31.48
Tangible Book Value, 3 Yr. CAGR %	-29.38	-56.57	-42.24	-4.68	181.95
Common Equity, 3 Yr. CAGR %	-2.97	59.86	24.06	16.48	35.57
Cash From Operations, 3 Yr. CAGR %	9.54	13.57	-13.27	6.18	30.38
Capital Expenditures, 3 Yr. CAGR %	2.66	21.5	35.43	56.89	61.71
Levered Free Cash Flow, 3 Yr. CAGR %	112.05	3.22	-59.25	-37.71	-28.22
Unlevered Free Cash Flow, 3 Yr. CAGR %	97.9	2.81	-47.45	-31.69	-29.14
Dividend Per Share, 3 Yr. CAGR %	14.75	14.96	15.15	15.21	15.24
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.94	7.4	9.69	15.08	21.58
Gross Profit, 5 Yr. CAGR %	6.59	7.13	9.97	15.79	23.22
EBITDA, 5 Yr. CAGR %	13.03	10.19	10.03	21.65	30
EBITA, 5 Yr. CAGR %	14.1	12.35	12.07	23.73	31.63
EBIT, 5 Yr. CAGR %	16.13	13	12.35	23.88	32.72
Earnings From Cont. Operations, 5 Yr. CAGR %	15.31	135.4	10.71	17.95	27.22
Net Income, 5 Yr. CAGR %	15.31	98.21	10.15	4.95	27.22
Normalized Net Income, 5 Yr. CAGR %	13.61	12.82	11.98	24.58	34.21
Diluted EPS Before Extra, 5 Yr. CAGR %	18.86	142.59	13.72	18.74	27.58
Accounts Receivable, 5 Yr. CAGR %	10.61	8.69	14.63	19.34	24.76
Inventory, 5 Yr. CAGR %	1.76	-0.68	13.26	18.92	28.13
Net Property, Plant and Equip., 5 Yr. CAGR %	1.72	2.82	10.06	18.18	24.47
Total Assets, 5 Yr. CAGR %	4.69	1.93	7.83	14.91	19.25
Tangible Book Value, 5 Yr. CAGR %	-14.43	-27.72	-32.01	-21.75	20.42
Common Equity, 5 Yr. CAGR %	-8.51	-1.68	1.85	40.34	36.3
Cash From Operations, 5 Yr. CAGR %	8.4	4.76	-5.15	12.76	20.93
Capital Expenditures, 5 Yr. CAGR %	4.78	11.48	23.28	37.37	41.38
Levered Free Cash Flow, 5 Yr. CAGR %	12.52	20.96	-15.17	-23.36	-11.04
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.54	20.31	-4.79	-19.18	-12.14
Dividend Per Share, 5 Yr. CAGR %	10.76	13.51	14.97	15.05	15.18